Comparison of the immune microenvironment of the oral cavity and cervix in healthy women

Cytokine

Volumn 64, Issue 2, 2013, Pages 597-604

  Fakhry, Carole ^a,b,c   Marks, Morgan A ^c   Gilman, Robert H ^c   Cabrerra, Lilia ^d   Yori, Pablo ^c   Kosek, Margaret ^c   Gravitt, Patti E ^c,e  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b Milton J Dance Jr Head and Neck Center   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d ASOCIACIÓN BENÉFICA PRISMA   (Peru)

^e PERDANA UNIVERSITY   (Malaysia)

Author keywords

Cervical; Immunoregulatory; Oral; Pro inflammatory; T cell

Indexed keywords

CONTRACEPTIVE AGENT; EOTAXIN; FIBROBLAST GROWTH FACTOR 2; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; INTERLEUKIN 9; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR BB; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADULT; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; GENOTYPE; HUMAN; IMMUNE MICROENVIRONMENT; IMMUNE RESPONSE; IMMUNE SYSTEM; MOUTH CAVITY; PRIORITY JOURNAL; T LYMPHOCYTE; UTERINE CERVIX;

CHLAMYDIA; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN PAPILLOMAVIRUS;

CERVICAL; IMMUNOREGULATORY; ORAL; PRO-INFLAMMATORY; T-CELL;

ADULT; BIOLOGICAL MARKERS; CELLULAR MICROENVIRONMENT; CERVIX UTERI; CONTRACEPTIVE AGENTS, FEMALE; FEMALE; HEALTH; HUMANS; MOUTH;

EID: 84885174767     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2013.08.009     Document Type: Article

References (40)

1. Edwards S., Carne C. Oral sex and the transmission of viral STIs. Sex Transm Infect 1998, 74:6-10.
2. Kent C.K., Chaw J.K., Wong W., Liska S., Gibson S., Hubbard G., et al. Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California, 2003. Clin Infect Dis 2005, 41:67-74.
3. Schlecht N.F., Burk R.D., Nucci-Sack A., Shankar V., Peake K., Lorde-Rollins E., et al. Cervical, anal and oral HPV in an adolescent inner-city health clinic providing free vaccinations. PLoS ONE 2012, 7:e37419.
4. Brown B., Blas M.M., Cabral A., Carcamo C., Gravitt P.E., Halsey N. Oral sex practices, oral human papillomavirus and correlations between oral and cervical human papillomavirus prevalence among female sex workers in Lima. Peru Int J STD AIDS 2011, 22:655-658.
5. Schlecht N.F., Rojas M., Lorde-Rollins E., Nucci-Sack A., Strickler H.D., Burk R.D., et al. Burden of cervical, anal, and oral HPV in an inner-city pre-vaccine adolescent population. J Urban Health 2012.
6. Rothenberg R.B., Scarlett M., del Rio C., Reznik D., O'Daniels C. Oral transmission of HIV. Aids 1998, 12:2095-2105.
7. Alexander R., Mestecky J. Neutralizing antibodies in mucosal secretions: IgG or IgA?. Curr HIV Res 2007, 5:588-593.
8. Nardelli-Haefliger D., Wirthner D., Schiller J.T., Lowy D.R., Hildesheim A., Ponci F., et al. Specific antibody levels at the cervix during the menstrual cycle of women vaccinated with human papillomavirus 16 virus-like particles. J Natl Cancer Inst 2003, 95:1128-1137.
9. Daud I.I., Scott M.E., Ma Y., Shiboski S., Farhat S., Moscicki A.B. Association between toll-like receptor expression and human papillomavirus type 16 persistence. Int J Cancer 2011, 128:879-886.
10. Hans M., Hans V.M. Toll-like receptors and their dual role in periodontitis: a review. J Oral Sci 2011, 53:263-271.
11. Schaefer T.M., Desouza K., Fahey J.V., Beagley K.W., Wira C.R. Toll-like receptor (TLR) expression and TLR-mediated cytokine/chemokine production by human uterine epithelial cells. Immunology 2004, 112:428-436.
12. Cutler C.W., Jotwani R. Dendritic cells at the oral mucosal interface. J Dent Res 2006, 85:678-689.
13. van Loon L.A., Krieg S.R., Davidson C.L., Bos J.D. Quantification and distribution of lymphocyte subsets and Langerhans cells in normal human oral mucosa and skin. J Oral Pathol Med 1989, 18:197-201.
14. Nicol A.F., Fernandes A.T., Grinsztejn B., Russomano F., ES J.R., Tristao A., et al. Distribution of immune cell subsets and cytokine-producing cells in the uterine cervix of human papillomavirus (HPV)-infected women: influence of HIV-1 coinfection. Diagn Mol Pathol 2005, 14:39-47.
15. Gravitt P.E., Peyton C.L., Alessi T.Q., Wheeler C.M., Coutlee F., Hildesheim A., et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol 2000, 38:357-361.
16. Coutlee F., Gravitt P., Kornegay J., Hankins C., Richardson H., Lapointe N., et al. Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples. J Clin Microbiol 2002, 40:902-907.
17. Bio-Rad Laboratories I. Bio-Plex suspension array system tech note. Hercules, CA; 2005.
18. Marks M.A., Eby Y., Howard R., Gravitt P.E. Comparison of normalization methods for measuring immune markers in cervical secretion specimens. J Immunol Methods 2012, 382:211-215.
19. Bio-Rad Laboratories I. Bio-plex pro human cytokine, chemokine, and growth factor assays technical, Bulletin; 2009. p. 1-4.
20. UCLA: Academic technology services SCG. Sidak-Holm: Adjusted p-values. [cited 17.07.2011];. http://www.ats.ucla.edu/stat/stata/code/sidak_holm.htm.
21. Nave H., Gebert A., Pabst R. Morphology and immunology of the human palatine tonsil. Anat Embryol 2001, 204:367-373.
22. Cutler C.W., Teng Y.T. Oral mucosal dendritic cells and periodontitis: many sides of the same coin with new twists. Periodontol 2000 2007, 45:35-50.
23. Daniels T.E. Human mucosal Langerhans cells: postmortem identification of regional variations in oral mucosa. J Invest Dermatol 1984, 82:21-24.
24. Castro-Junior A.B., Horta B.C., Gomes-Santos A.C., Cunha A.P., Silva Steinberg R., Nascimento D.S., et al. Oral tolerance correlates with high levels of lymphocyte activity. Cell Immunol 2012, 280:171-181.
25. Mowat A.M., Parker L.A., Beacock-Sharp H., Millington O.R., Chirdo F. Oral tolerance: overview and historical perspectives. Ann NY Acad Sci 2004, 1029:1-8.
26. Huse S.M., Ye Y., Zhou Y., Fodor A.A. A core human microbiome as viewed through 16S rRNA sequence clusters. PLoS ONE 2012, 7:e34242.
27. Ravel J., Gajer P., Abdo Z., Schneider G.M., Koenig S.S., McCulle S.L., et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci USA 2011, 108(Suppl 1):4680-4687.
28. Zaura E., Keijser B.J., Huse S.M., Crielaard W. Defining the healthy "core microbiome" of oral microbial communities. BMC Microbiol 2009, 9:259.
29. Ichinohe T., Pang I.K., Kumamoto Y., Peaper D.R., Ho J.H., Murray T.S., et al. Microbiota regulates immune defense against respiratory tract influenza a virus infection. Proc Natl Acad Sci USA 2011, 108:5354-5359.
30. Smith K., McCoy K.D., Macpherson A.J. Use of axenic animals in studying the adaptation of mammals to their commensal intestinal microbiota. Semin Immunol 2007, 19:59-69.
31. Round J.L., O'Connell R.M., Mazmanian S.K. Coordination of tolerogenic immune responses by the commensal microbiota. J Autoimmun 2010, 34:J220-5.
32. Jotwani R., Pulendran B., Agrawal S., Cutler C.W. Human dendritic cells respond to Porphyromonas gingivalis LPS by promoting a Th2 effector response in vitro. Eur J Immunol 2003, 33:2980-2986.
33. Pulendran B., Kumar P., Cutler C.W., Mohamadzadeh M., Van Dyke T., Banchereau J. Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo. J Immunol 2001, 167:5067-5076.
34. Pulendran B., Palucka K., Banchereau J. Sensing pathogens and tuning immune responses. Science 2001, 293:253-256.
35. Cutolo M., Sulli A., Capellino S., Villaggio B., Montagna P., Seriolo B., et al. Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity. Lupus 2004, 13:635-638.
36. Straub R.H. The complex role of estrogens in inflammation. Endocr Rev 2007, 28:521-574.
37. Marks M.A., Gravitt P.E., Burk R.D., Studentsov Y., Farzadegan H., Klein S.L. Progesterone and 17beta-estradiol enhance regulatory responses to human papillomavirus type 16 virus-like particles in peripheral blood mononuclear cells from healthy women. Clin Vaccine Immunol 2010, 17:609-617.
38. Kim J.S., Nag P., Landay A.L., Alves M., Cohn M.H., Bremer J.W., et al. Saliva can mediate HIV-1-specific antibody-dependent cell-mediated cytotoxicity. FEMS Immunol Med Microbiol 2006, 48:267-273.
39. Garcia-Pineres A.J., Hildesheim A., Herrero R., Trivett M., Williams M., Atmetlla I., et al. Persistent human papillomavirus infection is associated with a generalized decrease in immune responsiveness in older women. Cancer Res 2006, 66:11070-11076.
40. Stanley M. HPV - immune response to infection and vaccination. Infect Agent Cancer 2010, 5:19.